Panacea Capital (California) Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
12
- Investments
-
53
- Portfolio
-
36
- Exits
-
8
Panacea Capital (California) General Information
Company Description
Founded in 2017, Panacea Capital is a venture capital firm based in San Francisco, California. The firm incubates early-stage technologies and medical sector companies. The firm seeks to invest across emerging and established biotech, diagnostic, and medtech sectors.
Business Details
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- Silicon Valley
- San Francisco, CA
- United States
Panacea Capital (California) Investments (53)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Miragene | 01-May-2026 | Early Stage VC | Drug Discovery | Clinical Trials - Phase 1 | ||
| Connect Biopharmaceuticals | 30-Mar-2026 | Drug Discovery | Profitable | |||
| Seismic Pharmaceuticals | 30-Mar-2026 | Drug Delivery | Clinical Trials - Phase 3 | |||
| Lightning Biotherapeutics | 01-Mar-2026 | Biotechnology | Stealth | |||
| Neurochase | 17-Feb-2026 | Drug Delivery | Pre-Clinical Trials | |||
| Kainova Therapeutics | 10-Feb-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Biofront Therapeutics | 01-Jun-2025 | Drug Discovery | Generating Revenue | |||
| VelaVigo | 31-Dec-2024 | Biotechnology | Generating Revenue | |||
| Regatta Bio | 17-Dec-2024 | Seed Round | Drug Discovery | Pre-Clinical Trials | ||
| Human Longevity | 21-Aug-2024 | Later Stage VC | Other Healthcare Services | Generating Revenue |
Panacea Capital (California) Exits (8)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| HanchorBio | 29-May-2026 | IPO | |
| Feng Biosciences | 22-Aug-2025 | ||
| ImageneBio | 25-Jul-2025 | ||
| Day Zero Diagnostics | 13-Jun-2025 | ||
| HC Bioscience | 18-Mar-2025 | ||
| Kindstar Global | 16-Jul-2021 | ||
| Orion Biotech Opportunities | 13-May-2021 | IPO | |
| Zhaoke Ophthalmology | 28-Apr-2021 | IPO |
Panacea Capital (California) Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Panacea Capital (California) Investments by Industry, Year, and Region
Panacea Capital (California) Co-Investors (56)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Eos BioInnovation | 2 |
|
|
||
| VMS Group (Hong Kong) |
|
|
|||
| ARCH Venture Partners |
|
|
|||
| Emerging Technology Partners (Venture Capital) |
|
|
|||
| Omnes Capital |
|
|
Panacea Capital (California) FAQs
-
What is Panacea Capital (California)?
Founded in 2017, Panacea Capital is a venture capital firm based in San Francisco, California.
-
When was Panacea Capital (California) founded?
Panacea Capital (California) was founded in 2017.
-
Where is Panacea Capital (California) headquartered?
Panacea Capital (California) is headquartered in San Francisco, CA.
-
How many investments has Panacea Capital (California) made?
Panacea Capital (California) has made 53 investments.
-
What has Panacea Capital (California) invested in?
Panacea Capital (California) has made numerous investments in companies like Miragene, Connect Biopharmaceuticals, and Seismic Pharmaceuticals within the Drug Discovery and Drug Delivery industries.
-
What has Panacea Capital (California) invested in recently?
Panacea Capital (California)'s latest investment was on 01-May-2026 in Miragene, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process